Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Fibrogen Inc CS (NQ: FGEN )

0.3872 +0.0372 (+10.63%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,328,395
Open 0.3365
Bid (Size) 0.3781 (6)
Ask (Size) 0.3880 (20)
Prev. Close 0.3500
Today's Range 0.3365 - 0.3888
52wk Range 0.1800 - 2.930
Shares Outstanding 98,210,168
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why Are Chip Stocks Up Today?
Chip stocks are up today and investors wondering why will find all of the news explaining the rally in the sector on Wednesday. 
Via InvestorPlace
FibroGen Layoffs 2024: What to Know About the Latest FGEN Job Cuts
FibroGen layoffs are in the news Wednesday after the biopharmaceutical company announced plans to cut jobs after failed clinical trials. 
Via InvestorPlace
Topics Workforce
Exposures Layoff

Performance

YTD
-53.38%
-53.38%
1 Month
+3.39%
+3.39%
3 Month
-3.47%
-3.47%
6 Month
-68.52%
-68.52%
1 Year
-20.87%
-20.87%

More News

Read More
Why is Macrogenics (MGNX) Stock Down 28% Today?
Via InvestorPlace
Why Is FibroGen (FGEN) Stock Down 44% Today?
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
Earnings Scheduled For November 12, 2024
Via Benzinga
Earnings Outlook For FibroGen
Via Benzinga
FGEN Stock Earnings: FibroGen Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace
Nasdaq Surges Over 3%; Powell Industries Shares Spike Higher
Via Benzinga
Dow Jumps Over 200 Points; Kraft Heinz Shares Gain After Q2 Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
One Year, Five Trial Failures: FibroGen Terminates Pancreatic Cancer Treatment Program
Via Benzinga
Ground Cinnamon Recalls: What to Know as FDA Issues Alert Over Lead Levels
Via InvestorPlace
Topics Product Recall
Exposures Legal Product Safety
Why AMD Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
What's Going On With FibroGen Stock Tuesday?
Via Benzinga
Exposures Product Safety
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
Why HealthEquity Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Via Benzinga
FibroGen Stock Is Surging After The Bell: What's Going On?
Via Benzinga
Exposures Product Safety
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
7 Penny Biotech Stocks to Triple Your Investment
Via InvestorPlace
Investor Spotlight: Companies Poised for Growth Amid Recent Developments: VTAK, ESPR, FGEN, GSUN, INBS
Via AB Newswire
Why Beyond Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
FibroGen Shares Climb On Strong Q1 Sales
Via Benzinga
Tempur Sealy Posts Upbeat Earnings, Joins FibroGen, Coca-Cola Consolidated, Fabrinet And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Why Zeta Global Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.